Peptide-3
General Information
DRACP ID DRACP00337
Peptide Name Peptide-3
Sequence RRRRRRRRGGCX
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Coupling peptide
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HL-60 | Adult acute myeloid leukemia; Acute myeloid leukemia | Leukemia | IC50=6.24 µM | MTT assay | 3 h | 1 |
NCI-H358 | Minimally invasive lung adenocarcinoma | Carcinoma | IC50=8.41 µM | MTT assay | 3 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X(12)=Pemetrexed
Chiral L
Physicochemical Information
Formula C55H107N35O11S
Absent amino acids ADEFHIKLMNPQSTVWY
Common amino acids R
Mass 177310
Pl 12.98
Basic residues 8
Acidic residues 0
Hydrophobic residues 0
Net charge 8
Boman Index -11620
Hydrophobicity -285.83
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22076954
Title New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells
Doi 10.1002/psc.1407
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available